All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”
9F24002

Delineating the role of HTT Cis-Variants in the pathogenesis of Huntington disease

Public support

  • Provider

    Ministry of Education, Youth and Sports

  • Programme

  • Call for proposals

  • Main participants

    Všeobecná fakultní nemocnice v Praze

  • Contest type

    M2 - International cooperation

  • Contract ID

    31177/2022

Alternative language

  • Project name in Czech

    Delineating the role of HTT Cis-Variants in the pathogenesis of Huntington disease

  • Annotation in Czech

    Huntington disease (HD) is a fatal neurodegenerative disorder without disease modifying therapies. It is well known that HD is always caused by an expanded CAG repeat in the huntingtin (HTT) gene leading to translation of a mutant HTT (mHTT) protein with an expanded polyglutamine stretch in the whole body. However, a number of clinical trials aiming to reduce levels of mHTT has so far failed. There is an inverse correlation between the length of the CAG repeat and the age of onset of typical motor symptoms in HD, that define the age of onset of the clinical HD today. Several large genetic studies including genome-wide and transcription-wide association studies have revealed important genetic modifiers of age-of-onset with cisvariants in HTT suggested to exert major effects. However, these variants have not been considered in the characterization of clinical cohorts of individuals with HD including in the development of or inclusion for clinical trials aiming to modify disease progression. Also, the impact of the genetic variants on the function of mHTT or on neuropathology is not known. Here we propose to fill an important and urgent gap in the knowledge of clinical genetics in HD.

Scientific branches

  • R&D category

    AP - Applied research

  • OECD FORD - main branch

    30230 - Other clinical medicine subjects

  • OECD FORD - secondary branch

  • OECD FORD - another secondary branch

  • CEP - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    FP - Other medical fields

Solution timeline

  • Realization period - beginning

    Jun 1, 2024

  • Realization period - end

    May 31, 2027

  • Project status

    Z - Beginning multi-year project

  • Latest support payment

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP24-MSM-9F-R

  • Data delivery date

    Mar 8, 2024

Finance

  • Total approved costs

    5,918 thou. CZK

  • Public financial support

    5,918 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    0 thou. CZK